US › Healthcare

OUTLOOK THERAPEUTICS INC (OTLK)

US · Healthcare · Biotechnology

$0.49-2.40%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$9,000

Revenue YoY

-99.4%

Net profit

$-20.3M

EPS

$-0.09

EPS estimate

$-0.09

Net margin

-225,766.7%

EPS came in at -0.09 against a street estimate of -0.09 — a beat of 0.0%.

Key statistics

Market cap

$137.3M

Forward P/E

2.8

P/B

38.42

Book value

$-0.06

EPS (TTM)

$-0.67

52-week high

$2.54

52-week low

$0.16

50-day MA

$0.71

200-day MA

$0.70

Beta

0.67

Analyst view

Analysts rate OUTLOOK THERAPEUTICS INC a strong buy (3 buy, 1 hold, 0 sell out of 4) with an average price target of $5.03.

Shareholding

Insiders

12.64%

Institutions

16.70%

Largest institutional holders

Fund	Stake
Vanguard Capital Management, LLC	1.80%
Perceptive Advisors LLC	1.29%
Marshall Wace Asset Management Ltd	0.82%
BlackRock Inc	0.69%
Jane Street Group LLC	0.59%
Geode Capital Management, LLC	0.51%
Susquehanna International Group, LLP	0.40%
HRT FINANCIAL LLC	0.32%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for OUTLOOK THERAPEUTICS INC — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.